BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND LCK, YT16, 3932, P06239, ENSG00000182866, p56lck, pp58lck AND Prognosis
4 results:

  • 1. A multimodal radiomic machine learning approach to predict the lck expression and clinical prognosis in high-grade serous ovarian cancer.
    Zhan F; He L; Yu Y; Chen Q; Guo Y; Wang L
    Sci Rep; 2023 Sep; 13(1):16397. PubMed ID: 37773310
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identifying Immune-Specific Subtypes of Adrenocortical Carcinoma Based on Immunogenomic Profiling.
    Lu Q; Nie R; Luo J; Wang X; You L
    Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671489
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Lymphocyte-specific kinase expression is a prognostic indicator in ovarian cancer and correlates with a prominent B cell transcriptional signature.
    Hinchcliff E; Paquette C; Roszik J; Kelting S; Stoler MH; Mok SC; Yeung TL; Zhang Q; Yates M; Peng W; Hwu P; Jazaeri A
    Cancer Immunol Immunother; 2019 Sep; 68(9):1515-1526. PubMed ID: 31515669
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Evaluation of urinary plasminogen activator, its receptor, matrix metalloproteinase-9, and von Willebrand factor in pancreatic cancer.
    Harvey SR; Hurd TC; Markus G; Martinick MI; Penetrante RM; Tan D; Venkataraman P; DeSouza N; Sait SN; Driscoll DL; Gibbs JF
    Clin Cancer Res; 2003 Oct; 9(13):4935-43. PubMed ID: 14581368
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.